한글목차

세계의 뇌졸중 관리 시장은 2030년까지 542억 달러에 달할 전망

2023년에 376억 달러로 추정되는 세계의 뇌졸중 관리 시장은 2030년에는 542억 달러에 달하며, 분석 기간인 2023-2030년 CAGR은 5.4%로 성장할 것으로 예측됩니다. 뇌졸중 관리 리포트에서 분석한 부문의 하나인 진단은 CAGR 5.1%를 기록하며, 분석 기간 종료까지 359억 달러에 달할 것으로 예측됩니다. 뇌졸중 관리 치료 분야의 성장률은 분석 기간 중 CAGR 5.8%로 추정됩니다.

미국 시장은 102억 달러로 추정, 중국은 CAGR 8.7%로 성장 예측

미국의 뇌졸중 관리 시장은 2023년에 102억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 113억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2023-2030년 CAGR은 8.7%입니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 2.2%와 5.5%로 예측됩니다. 유럽에서는 독일이 CAGR 3.3%로 성장할 것으로 예측됩니다.

세계의 뇌졸중 관리 시장 - 주요 동향과 촉진요인 정리

뇌졸중 관리는 뇌에 혈액 공급이 갑자기 중단되어 잠재적인 뇌 손상과 기능 상실을 초래하는 뇌졸중 환자를 치료하고 재활하는 종합적인 접근법을 포함합니다. 허혈성 뇌졸중은 혈전을 용해시키는 조직 플라스미노겐 활성화제(tPA)와 같은 혈전 용해제를 사용하거나 혈전을 물리적으로 제거하는 혈전제거술과 같은 외과적 개입을 통해 치료합니다. 뇌내 출혈을 동반한 출혈성 뇌졸중은 출혈을 억제하고 뇌압을 낮추는 데 중점을 두고 수술적 시술를 시행하는 경우가 많습니다. 급성기 치료와 더불어 뇌졸중 관리에서는 항혈소판제, 항응고제, 혈압 조절, 생활습관 개선 등 2차 예방 전략을 통해 후속 뇌졸중 위험을 줄일 수 있습니다.

기술의 발전으로 뇌졸중 관리의 치료 성적이 눈에 띄게 향상되었습니다. 컴퓨터단층촬영(CT), 자기공명영상(MRI) 등 첨단 영상진단 기술의 발달로 신속하고 정확한 진단이 가능해져 허혈성 뇌졸중과 출혈성 뇌졸중을 감별하고 적절한 치료를 할 수 있게 되었습니다. 원격의료도 중요한 툴로 등장해 급성기 뇌졸중 치료에서 원격 진료와 신속한 의사결정을 가능하게 하고 있습니다. 로봇 치료 장비 및 가상현실 시스템과 같은 재활 기술은 뇌졸중 후 회복을 촉진하고 환자가 운동 능력과 기능적 능력을 보다 효과적으로 회복할 수 있도록 돕고 있습니다. 또한 뇌졸중 관리에서 인공지능(AI)의 활용이 증가하고 있으며, 뇌졸중 증상의 조기 발견과 예측 분석에 기반한 치료 계획의 최적화를 돕고 있습니다.

뇌졸중 관리 시장의 성장은 여러 가지 요인에 의해 촉진되고 있습니다. 고령화와 고혈압, 당뇨병, 비만과 같은 생활습관 관련 위험 요인으로 인한 뇌졸중 발병률 및 유병률 증가가 주요 촉진요인입니다. 최소침습 수술 기술 및 혁신적인 약물 치료법 개발을 포함한 의료 기술의 발전은 치료 결과 개선과 회복 시간 단축을 통해 시장 성장을 가속하고 있습니다. 원격의료 및 모바일 의료 용도의 확대는 특히 원격지 및 농촌 지역에서 뇌졸중 치료에 대한 접근성을 높이고 있습니다. 또한 조기 개입의 중요성에 대한 인식이 높아지고 뇌졸중 관리 서비스의 가용성이 높아지면서 수요를 촉진하고 있습니다. 정부의 뇌졸중 인식 개선 및 예방 프로그램에 대한 노력과 재정 지원도 시장 확대에 기여하고 있습니다. 또한 뇌졸중 치료 프로토콜의 개선과 새로운 치료법 개발에 초점을 맞춘 지속적인 연구개발은 시장에 새로운 기회를 창출하고 있습니다. 이러한 추세에 따라 뇌졸중 관리 시장은 기술 발전과 환자 중심의 종합적인 치료에 대한 관심이 높아짐에 따라 지속적인 성장이 예상되고 있습니다.

조사 대상 기업의 예(총 45건)

• Abbott Laboratories
• Boston Scientific Corporation
• GE Healthcare
• Heuron Co. Ltd.
• iSchemaView, Inc.(RapidAI)
• JIXING Pharmaceuticals
• Johnson & Johnson MedTech
• Koninklijke Philips N.V.
• Medtronic
• MicroPort Scientific Corporation
• NeuraSignal, Inc.
• Neurolutions, Inc.
• NeuroSafe Medical Co., Ltd.
• Penumbra, inc.
• Stryker Corporation;

목차

제1장 조사 방법

제2장 개요

• 시장 개요
• 주요 기업
• 시장 동향과 촉진요인
• 세계 시장의 전망

제3장 시장 분석

• 미국
• 캐나다
• 일본
• 중국
• 유럽
• 프랑스
• 독일
• 이탈리아
• 영국
• 스페인
• 러시아
• 기타 유럽
• 아시아태평양
• 호주
• 인도
• 한국
• 기타 아시아태평양
• 라틴아메리카
• 아르헨티나
• 브라질
• 멕시코
• 기타 라틴아메리카
• 중동
• 이란
• 이스라엘
• 사우디아라비아
• 아랍에미리트
• 기타 중동
• 아프리카

제4장 경쟁

영문목차

Global Stroke Management Market to Reach US$54.2 Billion by 2030

The global market for Stroke Management estimated at US$37.6 Billion in the year 2023, is expected to reach US$54.2 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2023-2030. Stroke Management Diagnostics, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$35.9 Billion by the end of the analysis period. Growth in the Stroke Management Therapeutic segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$10.2 Billion While China is Forecast to Grow at 8.7% CAGR

The Stroke Management market in the U.S. is estimated at US$10.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$11.3 Billion by the year 2030 trailing a CAGR of 8.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Stroke Management Market - Key Trends and Drivers Summarized

Stroke management encompasses a comprehensive approach to treating and rehabilitating patients who have suffered a stroke, which is a sudden interruption of blood supply to the brain, leading to potential brain damage and loss of function. Immediate medical intervention is critical in stroke management and often includes the use of thrombolytic agents like tissue plasminogen activator (tPA) to dissolve clots in ischemic stroke, or surgical interventions such as thrombectomy to physically remove the clot. For hemorrhagic strokes which involve bleeding in the brain, management focuses on controlling the bleeding and reducing pressure on the brain, often through surgical procedures. In addition to acute care, stroke management also involves secondary prevention strategies, including antiplatelet therapy, anticoagulants, blood pressure management, and lifestyle modifications to reduce the risk of subsequent strokes.

Technological advancements have significantly improved stroke management outcomes. The development of advanced imaging techniques, such as computed tomography (CT) and magnetic resonance imaging (MRI), allows for rapid and accurate diagnosis, helping to differentiate between ischemic and hemorrhagic strokes and guiding appropriate treatment. Telemedicine has also emerged as a crucial tool, enabling remote consultations and rapid decision-making in acute stroke care, especially in underserved areas. Rehabilitation technologies, including robotic therapy devices and virtual reality systems, have enhanced post-stroke recovery, allowing patients to regain mobility and functional abilities more effectively. Additionally, the use of artificial intelligence (AI) in stroke management is on the rise, aiding in the early detection of stroke symptoms and optimizing treatment plans based on predictive analytics.

The growth in the stroke management market is driven by several factors. Increasing incidence and prevalence of stroke due to aging populations and lifestyle-related risk factors such as hypertension, diabetes, and obesity are primary drivers. Advances in medical technology, including the development of minimally invasive surgical techniques and innovative drug therapies, are propelling market growth by improving treatment outcomes and reducing recovery times. The expansion of telemedicine and mobile health applications has broadened access to stroke care, particularly in remote and rural areas. Furthermore, rising awareness about the importance of early intervention and the availability of stroke management services is driving demand. Government initiatives and funding for stroke awareness and prevention programs are also contributing to market expansion. Additionally, continuous research and development efforts focused on improving stroke care protocols and developing new therapeutic options are generating new opportunities in the market. As these trends continue to evolve, the stroke management market is poised for sustained growth, driven by technological advancements and an increasing emphasis on comprehensive, patient-centered care.

Select Competitors (Total 45 Featured) -

• Abbott Laboratories
• Boston Scientific Corporation
• GE Healthcare
• Heuron Co. Ltd.
• iSchemaView, Inc. (RapidAI)
• JIXING Pharmaceuticals
• Johnson & Johnson MedTech
• Koninklijke Philips N.V.
• Medtronic
• MicroPort Scientific Corporation
• NeuraSignal, Inc.
• Neurolutions, Inc.
• NeuroSafe Medical Co., Ltd.
• Penumbra, inc.
• Stryker Corporation;

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Global Economic Update
  • Stroke Management - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increasing Incidence of Stroke Propels Demand for Management Solutions
  • Technological Advancements in Imaging Techniques Strengthen Diagnostic Accuracy
  • Expansion of Telemedicine Broadens Access to Acute Stroke Care
  • Development of Minimally Invasive Surgical Techniques Drives Market Growth
  • Innovative Drug Therapies Enhance Treatment Outcomes and Spur Market Expansion
  • Rising Prevalence of Lifestyle-Related Risk Factors Expands Addressable Market Opportunity
  • Adoption of AI and Predictive Analytics in Early Stroke Detection Throws Spotlight on Advanced Technologies
  • Integration of Mobile Health Applications in Stroke Management Sustains Market Growth
  • Enhanced Rehabilitation Technologies Propel Post-Stroke Recovery Market
  • Expanding Healthcare Infrastructure in Emerging Markets Drives Adoption
  • Improved Secondary Prevention Strategies Drive Long-Term Market Growth
  • Growing Use of Thrombectomy Procedures Enhances Acute Stroke Management
  • Advances in Robotic Therapy Devices Expand Rehabilitation Market
  • Increasing Use of Wearable Devices for Monitoring Post-Stroke Patients Generates Demand
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Stroke Management Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Stroke Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Stroke Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 4: World 16-Year Perspective for Stroke Management by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Diagnostics Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Diagnostics Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 7: World 16-Year Perspective for Diagnostics Type by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Therapeutic Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Therapeutic Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 10: World 16-Year Perspective for Therapeutic Type by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Ischemic Stroke Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Ischemic Stroke Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 13: World 16-Year Perspective for Ischemic Stroke Application by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Hemorrhagic Stroke Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Hemorrhagic Stroke Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 16: World 16-Year Perspective for Hemorrhagic Stroke Application by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Stroke Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 17: USA Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 18: USA Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 19: USA 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 20: USA Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 21: USA Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 22: USA 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 23: Canada Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 24: Canada Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 25: Canada 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 26: Canada Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 27: Canada Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 28: Canada 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
• JAPAN
  • Stroke Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 29: Japan Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 30: Japan Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 31: Japan 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 32: Japan Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 33: Japan Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 34: Japan 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
• CHINA
  • Stroke Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 35: China Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 36: China Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 37: China 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 38: China Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 39: China Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 40: China 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
• EUROPE
  • Stroke Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 41: Europe Recent Past, Current & Future Analysis for Stroke Management by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 42: Europe Historic Review for Stroke Management by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 43: Europe 16-Year Perspective for Stroke Management by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 44: Europe Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Europe Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 46: Europe 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 47: Europe Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 48: Europe Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 49: Europe 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
• FRANCE
  • Stroke Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 50: France Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 51: France Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 52: France 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 53: France Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 54: France Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 55: France 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
• GERMANY
  • Stroke Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 56: Germany Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 57: Germany Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 58: Germany 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 59: Germany Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 60: Germany Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 61: Germany 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 62: Italy Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 63: Italy Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 64: Italy 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 65: Italy Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 66: Italy Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 67: Italy 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Stroke Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 68: UK Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 69: UK Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 70: UK 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 71: UK Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 72: UK Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 73: UK 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
• SPAIN
  • TABLE 74: Spain Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 75: Spain Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 76: Spain 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 77: Spain Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 78: Spain Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 79: Spain 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
• RUSSIA
  • TABLE 80: Russia Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 81: Russia Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 82: Russia 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 83: Russia Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 84: Russia Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 85: Russia 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 87: Rest of Europe Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 88: Rest of Europe 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 90: Rest of Europe Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 91: Rest of Europe 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Stroke Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Stroke Management by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 93: Asia-Pacific Historic Review for Stroke Management by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 94: Asia-Pacific 16-Year Perspective for Stroke Management by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 96: Asia-Pacific Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 97: Asia-Pacific 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 99: Asia-Pacific Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 100: Asia-Pacific 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
• AUSTRALIA
  • Stroke Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
  • TABLE 101: Australia Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 102: Australia Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 103: Australia 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 104: Australia Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 105: Australia Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 106: Australia 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
• INDIA
  • Stroke Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
  • TABLE 107: India Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 108: India Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 109: India 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 110: India Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 111: India Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 112: India 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
• SOUTH KOREA
  • TABLE 113: South Korea Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 114: South Korea Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 115: South Korea 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 116: South Korea Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 117: South Korea Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 118: South Korea 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 120: Rest of Asia-Pacific Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 121: Rest of Asia-Pacific 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 123: Rest of Asia-Pacific Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
• LATIN AMERICA
  • Stroke Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
  • TABLE 125: Latin America Recent Past, Current & Future Analysis for Stroke Management by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 126: Latin America Historic Review for Stroke Management by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 127: Latin America 16-Year Perspective for Stroke Management by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • TABLE 128: Latin America Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 129: Latin America Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 130: Latin America 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 131: Latin America Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 132: Latin America Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 133: Latin America 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
• ARGENTINA
  • TABLE 134: Argentina Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 135: Argentina Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 136: Argentina 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 137: Argentina Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 138: Argentina Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 139: Argentina 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
• BRAZIL
  • TABLE 140: Brazil Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 141: Brazil Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 142: Brazil 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 143: Brazil Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 144: Brazil Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 145: Brazil 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
• MEXICO
  • TABLE 146: Mexico Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 147: Mexico Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 148: Mexico 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 149: Mexico Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 150: Mexico Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 151: Mexico 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
• REST OF LATIN AMERICA
  • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 153: Rest of Latin America Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 154: Rest of Latin America 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 156: Rest of Latin America Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 157: Rest of Latin America 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
• MIDDLE EAST
  • Stroke Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
  • TABLE 158: Middle East Recent Past, Current & Future Analysis for Stroke Management by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 159: Middle East Historic Review for Stroke Management by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 160: Middle East 16-Year Perspective for Stroke Management by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • TABLE 161: Middle East Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 162: Middle East Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 163: Middle East 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 164: Middle East Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 165: Middle East Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 166: Middle East 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
• IRAN
  • TABLE 167: Iran Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 168: Iran Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 169: Iran 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 170: Iran Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 171: Iran Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 172: Iran 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
• ISRAEL
  • TABLE 173: Israel Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 174: Israel Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 175: Israel 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 176: Israel Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 177: Israel Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 178: Israel 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
• SAUDI ARABIA
  • TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 180: Saudi Arabia Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 181: Saudi Arabia 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 183: Saudi Arabia Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 184: Saudi Arabia 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
• UNITED ARAB EMIRATES
  • TABLE 185: UAE Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 186: UAE Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 187: UAE 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 188: UAE Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 189: UAE Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 190: UAE 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
• REST OF MIDDLE EAST
  • TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 192: Rest of Middle East Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 193: Rest of Middle East 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 195: Rest of Middle East Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 196: Rest of Middle East 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030
• AFRICA
  • Stroke Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
  • TABLE 197: Africa Recent Past, Current & Future Analysis for Stroke Management by Type - Diagnostics Type and Therapeutic Type - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 198: Africa Historic Review for Stroke Management by Type - Diagnostics Type and Therapeutic Type Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 199: Africa 16-Year Perspective for Stroke Management by Type - Percentage Breakdown of Value Revenues for Diagnostics Type and Therapeutic Type for the Years 2014, 2024 & 2030
  • TABLE 200: Africa Recent Past, Current & Future Analysis for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 201: Africa Historic Review for Stroke Management by Application - Ischemic Stroke Application and Hemorrhagic Stroke Application Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 202: Africa 16-Year Perspective for Stroke Management by Application - Percentage Breakdown of Value Revenues for Ischemic Stroke Application and Hemorrhagic Stroke Application for the Years 2014, 2024 & 2030

IV. COMPETITION